Sign Up Today and Learn More About Genome Insight Stock
Invest in or calculate the value of your shares in Genome Insight or other pre-IPO companies through EquityZen's platform.
Genome Insight Stock (GENI)
Genome Insight is a developer of a genome sequence (WGS) analysis and interpretation platform.
About Genome Insight Stock
Founded
2020
Headquarters
La Jolla, CA, US
Industries
Data and Analytics, Science and Engineering, Health Care
Genome Insight Press Mentions
Stay in the know about the latest news on Genome Insight
Method and apparatus for determining copy number variation profile using read …
patents • May 04, 2025
Method and apparatus for detecting minimal residual disease using tumor …
patents • Apr 02, 2025
Method and apparatus for detecting minimal residual disease using tumor …
patents • Apr 02, 2025
Method and system for analyzing sequences
patents • Nov 07, 2024
Inocras Inc. on LinkedIn: #wholegenome #wgs #genetictesting #dna #dnatesting #cancergenomics…
linkedin • May 24, 2024
Join now and verify your accreditation status to gain access to:
- Genome Insight Current Valuation
- Genome Insight Stock Price
- Genome Insight Management
- Available deals in Genome Insight and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Genome Insight Cap Table and Funding History by Share Class and Liquidity Preferences
- Genome Insight Revenue and Financials
- Genome Insight Highlights
- Genome Insight Business Model
- Genome Insight Risk Factors
- Genome Insight Research Report from SACRA Research
Trading Genome Insight Stock
How to invest in Genome Insight stock?
Accredited investors can buy pre-IPO stock in companies like Genome Insight through EquityZen funds. These investments are made available by existing Genome Insight shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Genome Insight stock?
Shareholders can sell their Genome Insight stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
